The company offers a clinical vetting process and care management pathway for individuals suffering from substance use disorders.

The feature allows users to obtain real-time CGM data on their Watch without an iPhone present.

Also, a gastric cancer detection tool in India has received a breakthrough designation from the US FDA.

Also, Consultmed has released a new genAI feature on its referral management software.

Nick Altebrando has joined Ada as chief product officer, and Yury Rozenman will serve as the company's SVP of business development.

Dr. Guido Giunti discusses patient involvement and the necessity of being forward-thinking in creating digital therapeutics.